Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels.
There is evidence that genetic factors affect nitric oxide formation and that sequence variants in the nitric oxide synthase genes contribute to the observed variance of nitric oxide levels in exhaled air (fraction of expired nitric oxide, FENO) in subjects with asthma. We identified a strong association between a known functional NOS3 missense sequence variant in the endothelial nitric oxide gene (G894T) and FENO level in a cohort of subjects with asthma. Age- and sex-adjusted FENO levels were lowest in asthmatic subjects with the TT genotype (geometric mean FENO [95% CI] = 7.17 [4.48 to 11.48] ppb) and were significantly higher in those with either the GT genotype (geometric mean FENO [95% CI] = 17.11 [13.80 to 21.23] ppb) or the GG genotype (geometric mean FENO [95% CI] = 12.06 [9.91 to 14.67] ppb) (F2,59 = 5.97, p = 0.004). The G894T DNA variant explained 16.3% of the residual variance in FENO levels. Our results demonstrate that the endothelial nitric oxide synthase, a nitric oxide synthase constitutively expressed in epithelial cells, plays an important role in determining measured levels of exhaled nitric oxide, a marker of the asthmatic condition.
Published In/Presented At
Storm van's Gravesande, K., Wechsler, M. E., Grasemann, H., Silverman, E. S., Le, L., Palmer, L. J., & Drazen, J. M. (2003). Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels. American journal of respiratory and critical care medicine, 168(2), 228–231. https://doi.org/10.1164/rccm.200212-1491BC
Medicine and Health Sciences
Department of Medicine